Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Concerning Duvelisib & Small cell lymphoma / Chronic Lymphocytic Leukemia (CLL), Duvelisib is approved by the FDA for relapsed/refractory chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), but it does not have an EMA marketing authorisation in the EU (3)
Duvelisib achieves significant efficacy in Chronic lymphocytic leukemia (CLL) / Small lymphocytic lymphoma (SLL) even in patients with high-risk features. Duvelisib therapy may be particularly appropriate for patients not optimally suited to treatment with [Bruton's tyrosine kinase inhibitors (BTK)](brain://-By…